Cargando…
The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.
Analysis of pathological data in the 10th year of follow-up of a multicentre trial of the management of operable breast cancer has confirmed the correlation of prognosis with tumour grade, tumour size and lymph-node status. For each factor examined there was no difference in survival between the 2 t...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011009/ https://www.ncbi.nlm.nih.gov/pubmed/7044401 |
_version_ | 1782136441510297600 |
---|---|
author | Elston, C. W. Gresham, G. A. Rao, G. S. Zebro, T. Haybittle, J. L. Houghton, J. Kearney, G. |
author_facet | Elston, C. W. Gresham, G. A. Rao, G. S. Zebro, T. Haybittle, J. L. Houghton, J. Kearney, G. |
author_sort | Elston, C. W. |
collection | PubMed |
description | Analysis of pathological data in the 10th year of follow-up of a multicentre trial of the management of operable breast cancer has confirmed the correlation of prognosis with tumour grade, tumour size and lymph-node status. For each factor examined there was no difference in survival between the 2 treatment groups ("watch policy" and radiotherapy) but patients in the WP group whose tumours were of Grade II or III or greater than 2 cm, or with lymph-node metastases, had a greater chance of local recurrence. Cellular reaction had no relationship with prognosis, except in patients with Grade III tumours. The clinical relevance and application of these results are discussed. |
format | Text |
id | pubmed-2011009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1982 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20110092009-09-10 The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. Elston, C. W. Gresham, G. A. Rao, G. S. Zebro, T. Haybittle, J. L. Houghton, J. Kearney, G. Br J Cancer Research Article Analysis of pathological data in the 10th year of follow-up of a multicentre trial of the management of operable breast cancer has confirmed the correlation of prognosis with tumour grade, tumour size and lymph-node status. For each factor examined there was no difference in survival between the 2 treatment groups ("watch policy" and radiotherapy) but patients in the WP group whose tumours were of Grade II or III or greater than 2 cm, or with lymph-node metastases, had a greater chance of local recurrence. Cellular reaction had no relationship with prognosis, except in patients with Grade III tumours. The clinical relevance and application of these results are discussed. Nature Publishing Group 1982-05 /pmc/articles/PMC2011009/ /pubmed/7044401 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Elston, C. W. Gresham, G. A. Rao, G. S. Zebro, T. Haybittle, J. L. Houghton, J. Kearney, G. The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. |
title | The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. |
title_full | The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. |
title_fullStr | The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. |
title_full_unstemmed | The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. |
title_short | The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. |
title_sort | cancer research campaign (king's/cambridge trial for early breast cancer: clinico-pathological aspects. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011009/ https://www.ncbi.nlm.nih.gov/pubmed/7044401 |
work_keys_str_mv | AT elstoncw thecancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT greshamga thecancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT raogs thecancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT zebrot thecancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT haybittlejl thecancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT houghtonj thecancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT kearneyg thecancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT elstoncw cancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT greshamga cancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT raogs cancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT zebrot cancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT haybittlejl cancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT houghtonj cancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects AT kearneyg cancerresearchcampaignkingscambridgetrialforearlybreastcancerclinicopathologicalaspects |